Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of SHR0302 with Itraconazole in Healthy Subjects
NCT05404724Phase 1Completed
- Sponsor
- Hengrui
- Start
- Jun 2022
- Primary completion
- Jul 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of ivarmacitinib in rheumatoid arthritis (RA), sponsored by Hengrui. Primary endpoints: Area under the concentration-time curve from time zero to the last measurable concentration, Area under the concentration-time curve from time zero to infinity and 1 more. Started Jun 2022; status: completed.
02
Drugs
ivarmacitinib
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT05404724.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05404724.